Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line

Biology of Blood and Marrow Transplantation

Volumn 4, Issue 3, 1998, Pages 119-127

  Bauer, Gerhard ^a   Sauter, Sybille ^b   Ibanez, Carlos ^b   Rice, C Robert ^a   Valdez, Penelope ^a   Jolly, Dong ^b   Kohn, Donald B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

CD 34+ hematopoietic progenitor cells; Gene therapy; HIV 1; Ribozyme

Indexed keywords

CD34 ANTIGEN; RIBOZYME;

ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; COMPARATIVE STUDY; DOG; GENE TRANSFER; GENE VECTOR; HEMATOPOIETIC STEM CELL; HUMAN; PHYSIOLOGY; RETROVIRUS;

ANIMALS; ANTIGENS, CD34; DOGS; DRUG RESISTANCE, MICROBIAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; RETROVIRIDAE; RNA, CATALYTIC;

EID: 0032253230     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.1998.v4.pm9923409     Document Type: Article

References (39)

1. Kohn DB: The current status of gene therapy using hematopoietic stem cells. Current Opinions in Pediatrics 7:56, 1995.
2. Mann R, Mulligan RC, Baltimore D: Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153, 1983.
3. Miller AD: Retrovirus packaging cells. Hum Gene Ther 1:5, 1990.
4. Rasheed S, Gardner MB, Chan E: Amphotropic host range of naturally occurring wild mouse leukemia viruses. J Virol 19:13, 1976.
5. Kotani H, Newton PB, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, McGarrity GJ: Improved methods of retroviral vector transduction and production for human gene therapy. Hum Gene Ther 5:19, 1994.
6. Dunbar CE: Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease. Ann Rev Med 47:11, 1996.
7. Chakraborty AK, Zink MA, Hodgson CP: Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy. Cancer Gene Ther 1:113, 1994.
8. Patience C, Takeuchi Y, Cosset FL, Weiss R: Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells. J Virol 72:2671, 1998.
9. Barber JR, Jolly DJ, Respess JG, Chang SMW: Chiron Viagene. Packaging cells. US patent 5716,832. 1998 February 10.
10. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392, 1993.
11. Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK: High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 69:7430, 1995.
12. Rigg RJ, Chen J, Dando JS, Forestell SP, Plavec I, Böhnlein E: A novel human amphotropic packaging cell line: high titer, complement resistance and improved safety. Virology 218:290, 1996.
13. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980, 1989.
14. Zhou C, Bahner I, Larson G, Zaia JA, Rossi JJ, Kohn DB: Anti-HIV-1 hammerhead ribozymes transduced by retroviral vectors inhibit HIV-1 replication in human T lymphocytes. Gene 149:33, 1994.
15. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986.
16. Miller DA, Verma IM: Two base changes restore infectivity to a noninfectious molecular clone of Moloney murine leukemia virus (pMLV-1). J Virol 49:214, 1984.
17. Thomsen DR, Stenberg RM, Goins WF, Stinski MF: Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci USA 81:659, 1984.
18. Simonsen CC, Levinson AD: Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc Natl Acad Sci USA 80:2495, 1983.
19. Chattopadhyay SK, Oliff AI, Linemeyer DL, Lander MR, Lowy DR: Genomes of murine leukemia viruses isolated from wild mice. J Virol 39:777, 1981.
20. Mulsant P, Gatignol A, Dalens M, Tiraby G: Phleomycin resistance as a dominant selectable marker in CHO cells. Somat Cell Mol Gen 14:243, 1988.
21. Printz M, Reynolds J, Mento SJ, Jolly D, Kowal K, Sajjadi N: Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays. Gene Ther 2:143, 1995.
22. Burns JC, Friedman T, Driever W, Burrascano M, Yee JK: Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90:8033, 1993.
23. Food and Drug Administration: Points to Consider: Somatic Cell and Gene Therapy. Bethesda, MD, Center for Biologics, Food and Drug Administration. n.d.
24. Food and Drug Administration: Points to Consider: Cell Lines Used to Produce Biologicals. Bethesda, MD, Center for Biologics, Food and Drug Administration. n.d.
25. Food and Drug Administration: Points to Consider: Biologicals Produced by Recombinant DNA Technology. Bethesda, MD, Center for Biologics, Food and Drug Administration. n.d.
26. + cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes. Blood 89:2259, 1997.
27. + peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony stimulating factor. Blood 89:4299, 1997.
28. Nolta JA, Yu XJ, Bahner I, Kohn DB: Retroviral mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. J Clin Invest 90:343, 1992.
29. Collins LS, Dorshkind K: A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol 138:1082, 1987.
30. + hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits HIV-1 replication in the myelomonocytic cells produced in long-term culture. J Virol 70:4352, 1996.
31. Nolta JA, Kohn DB: Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1:257, 1990.
32. Russell DW, Berger MS, Miller AD: The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum Gene Ther 6:635, 1995.
33. Le Doux JM, Morgan JR, Snow RG, Yarmush ML: Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol 70:6468, 1996.
34. van Beusechem WW, Bakx TA, Kaptein LCM, Bart JAK, Kukler A, Braakman E, Valerio D: Retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells: effect of viral titers on transduction efficiency. Hum Gene Ther 4:239, 1993.
35. Forestell SP, Dando JS, Chen J, de Vries P, Böhnlein E, Rigg RJ: Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer. Gene Ther 4:600, 1997.
36. Davis JL, Witt RM, Gross PR, Hokanson CA, Jungles S, Cohen LK, Danos O, Spratt SK: Retroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficiencies. Hum Gene Ther 8:1459, 1997.
37. Forestell SP, Böhnlein E, Rigg RJ: Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Ther 2:723, 1995.
38. Kohn DB, Nolta JA, Crooks G: Clinical trials of gene therapy using hematopoietic stem cells. In: SJ Forman, KG Blume, ED Thomas (eds) Hematopoietic Cell Transplantation. 2nd edition. Boston, MA: Blackwell Scientific Publications. In press.
39. Zaia JA, Rossi JJ, Ito JI, Castanotto D, Li SXL, Yam P, Bauer G, Valdez P, Rice CR, Rothschild JC, Li H, Banh VN, Sauter S, Peters G, Couture L, Jolly DJ, Sniecinski I, Forman SJ, Kohn DB: Autologous stem cell transplantation using retrovirus-transduced peripheral blood progenitor cells in HIV-infected subjects: six month results. American Society for Gene Therapy, Seattle, WA, 206, 1998. [abstr]